Site search CONTACT US LOG IN Русскиҋ 中文


Alaris announces partnership with Labstat International and completes $49 million bought deal financing

June 2012
Share on LinkedIn Share on Facebook Share on Twitter Email this article Print this article

On June 6, 2012, Alaris Royalty Corp. (TSX: AD) announced that it had entered into a new partnership agreement with Labstat International ULC to form Labstat International LP ("Labstat" or the "Partnership"). Alaris contributed $41,200,000 (the "Labstat Contribution") to the Partnership in return for an initial $6,180,000 annual preferred distribution.

Following the completion of the Labstat Contribution, Alaris entered into an agreement with underwriters led by Acumen Capital Finance Partners Limited, pursuant to which Alaris would sell shares, on a "bought-deal" basis, for total gross proceeds of $44,070,000. Alaris also granted the underwriters an over-allotment option to purchase additional common shares from treasury. The offering closed on June 27, 2012, raising gross proceeds of approximately $49 million.

Labstat is a globally recognized analytical laboratory dedicated to the analysis of tobacco and tobacco products.

Gowlings acted for a financial institution which provided financing to Labstat International ULC to help facilitate the transaction with Alaris with a team led by Harold Chataway and that included Richard Dusome and Christine Marchetti.


Connect with us on LinkedIn Follow Us on Twitter Like Us on Facebook Follow Us on YouTube Follow Us on SlideShare Subscribe to Gowlings Newsletters
© 2016 Gowling Lafleur Henderson LLP. All rights reserved.